THE INCREASE OF CIRCULATING CD4(+) T-CELLS WITH EFFECTOR PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS MAY BE REVERTED AFTER BELIMUMAB THERAPY
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2016）
关键词
T lymphocytes,belimumab,systemic lupus erythematosus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要